A 28-year-old with a history of abnormality of the distal radius. Patient elected to have it followed on ultrasound.
[[{"type":"media","view_mode":"media_crop","fid":"13959","attributes":{"alt":"","class":"media-image","id":"media_crop_1257351547079","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"672","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 6px;","title":" ","typeof":"foaf:Image"}}]]
Image 1
[[{"type":"media","view_mode":"media_crop","fid":"13954","attributes":{"alt":"","class":"media-image","id":"media_crop_2126072799087","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"673","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 6px;","title":" ","typeof":"foaf:Image"}}]]
Image 2
[[{"type":"media","view_mode":"media_crop","fid":"13955","attributes":{"alt":"","class":"media-image","id":"media_crop_4527142359705","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"666","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 6px;","title":" ","typeof":"foaf:Image"}}]]
Image 3: Baseline
[[{"type":"media","view_mode":"media_crop","fid":"13956","attributes":{"alt":"","class":"media-image","id":"media_crop_6623231976971","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"667","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 6px;","title":" ","typeof":"foaf:Image"}}]]
Image 4: Three-month follow-up ultrasound
[[{"type":"media","view_mode":"media_crop","fid":"13957","attributes":{"alt":"","class":"media-image","id":"media_crop_3421241025204","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"668","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 6px;","title":" ","typeof":"foaf:Image"}}]]
Image 5
[[{"type":"media","view_mode":"media_crop","fid":"13958","attributes":{"alt":"","class":"media-image","id":"media_crop_8779194874350","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"669","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 6px;","title":" ","typeof":"foaf:Image"}}]]
Image 6: Six-month follow-up ultrasound
Diagnosis: Giant cell tumor with ABC formation
Ronald S. Adler, PhD, MD - Editor
Former Chief, Ultrasound and Body CT, Hospital for Special Surgery
Attending Radiologist, Hospital for Special Surgery
Professor of Radiology, Weill College of Medicine of Cornell University
Case courtesy Hospital for Special Surgery. ©2013 Hospital for Special Surgery.
Click here for more Case Studies from HSS.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.